PTPRC and non-small cell lung carcinoma: Only 32% of stage IV non-small-cell lung cancer (NSCLC) patients had ≥2 CellSearch CTCs/7.5 ml blood [5] yet when CTC number was defined as CD45− cells unable to pass through 8 μm filter pores, this percentage rose to 83% [6].